IL6 and cancer: It was shown that neutralization of human IL-6 by monoclonal antibodies reduced tumor-induced cachexia independent of an effect on tumor growth in human tumor xenograft models in nude mice, supporting a role for tumor-derived IL-6 in cancer cachexia [82].